SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma.

Journal of clinical pathology(2023)

引用 0|浏览7
暂无评分
摘要
Our study is the first to shed light on the intricate relationship between SSTR2 and EGFR in NPC and provides new insights into the potential benefits of EGFR targeted therapy for patients with high SSTR2 expression. Additionally, SSTR2 has potential as a new biomarker for poor prognosis in NPC patients.
更多
查看译文
关键词
biomarkers, tumor, immunohistochemistry, head and neck neoplasms, proteins
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要